Bitcoin price today: dips to $92k as Fed cut doubts spark risk-off mood
DEXCOM INC (NASDAQ:DXCM) President and COO Jacob Steven Leach, has recently purchased shares of the company, according to a Form 4 filing with the Securities and Exchange Commission. On November 10, 2025, Leach acquired a total of 18,200 shares of DEXCOM common stock in two separate transactions, with the price per share ranging from $54.34 to $55.55. The total value of these purchases amounted to $1,001,701.
The first transaction involved the purchase of 15,700 shares at a weighted average price of $54.977, while the second transaction consisted of 2,500 shares at a weighted average price of $55.4252. Following these transactions, Leach directly owns 331,697 shares of DEXCOM INC.
In addition, Leach indirectly owns 47,296 shares through Family Holdings.
The transactions were signed on behalf of Jacob Steven Leach by Jereme M. Sylvain, as Attorney-in-Fact.
In other recent news, DexCom reported its third-quarter earnings for 2025, surpassing analysts’ expectations with an earnings per share (EPS) of $0.61 compared to the forecasted $0.57, marking a 7.02% earnings surprise. Revenue also exceeded predictions, reaching $1.21 billion against an anticipated $1.18 billion, which represents a 2.54% surprise. U.S. revenue grew by 21% year-over-year to $851.9 million, while international revenue saw an 18% organic increase to $357.4 million. Despite these strong results, some analysts have adjusted their price targets for DexCom. Bernstein lowered its price target to $84, citing valuation concerns, while Piper Sandler reduced its target to $75 due to growth concerns. BTIG also adjusted its price target to $85 following the earnings report, expressing concerns about growth. Canaccord Genuity decreased its price target to $99, mentioning quality costs, but maintained a Buy rating. These recent developments reflect a mix of positive earnings performance and cautious outlooks from analysts.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.